Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. (GRU)

  • SEC News
  • April 30, 2026, 04:08 UTC
  • 0
  • 0 comments

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Comment Full text

SINGAPORE INDEX FUND (S45U)

  • SEC News
  • April 30, 2026, 04:08 UTC
  • 0
  • 0 comments

General Announcement: Net Asset Value ("NAV") as of 29 April 2026

Comment Full text

CGS INTERNATIONAL SECURITIES SINGAPORE PTE. LTD. (GRU)

  • SEC News
  • April 30, 2026, 04:07 UTC
  • 0
  • 0 comments

General Announcement: NET ASSET VALUE ("NAV") PER UNIT

Comment Full text

MALAYSIA SMELTING CORP BHD 100 (NPW)

  • SEC News
  • April 30, 2026, 02:52 UTC
  • 0
  • 0 comments

Annual Reports and Related Documents:

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 30, 2026, 02:20 UTC
  • 0
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 30, 2026, 02:20 UTC
  • 0
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (YYR)

  • SEC News
  • April 30, 2026, 02:20 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 30, 2026, 02:19 UTC
  • 0
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text

LION GLOBAL INVESTORS LIMITED (YYR)

  • SEC News
  • April 30, 2026, 02:19 UTC
  • 0
  • 0 comments

General Announcement: Net Tangible Assets ("NTA") per unit

Comment Full text

UOB ASSET MANAGEMENT LTD (JK8)

  • SEC News
  • April 30, 2026, 02:19 UTC
  • 0
  • 0 comments

General Announcement: Net Asset Value ("NAV") per Unit

Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next

Search

News categories

  • Technical Exchange News(12156)
  • Event(5779)
  • SEC News(257821)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152382)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin